Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
60.9% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
4
users have commented on this narrative
38
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
31.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
4
users have commented on this narrative
57
users have followed this narrative
New
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
19.7% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
1
users have commented on this narrative
7
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Hecla Mining
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
US High-Grade Silver Assets Will Capitalize On Solar And Electrification
Key Takeaways Strategic investment in high-grade U.S. silver assets and operational improvements position Hecla to benefit from rising, long-term silver demand and enhanced profitability. Strong balance sheet, disciplined capital allocation, and industry-leading ESG profile enable future growth opportunities, lower risk, and sustained multi-year revenue expansion.
View narrative
US$7.48
FV
17.9% undervalued
intrinsic discount
-2.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
13 days ago
author updated this narrative
Surgery Partners
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Ambulatory Surgery Trends And Aging Will Expand Market Reach
Key Takeaways Growth is driven by rising surgical case volumes in lower-cost centers and expanded specialties, supported by demographic trends and strategic network expansion. Margin improvements stem from investments in higher-acuity care, operational efficiencies, and enhanced revenue management.
View narrative
US$31.36
FV
29.4% undervalued
intrinsic discount
9.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
13 days ago
author updated this narrative
ICU Medical
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Aging Populations And Emerging Markets Will Expand Hospital Care
Key Takeaways Demographic trends and rising healthcare spending are driving strong demand, supporting growth across key business segments and expanding ICU Medical's addressable market. New product rollouts, acquisition synergies, and a focus on recurring revenues are boosting margins, operational efficiency, and earnings stability.
View narrative
US$186.20
FV
30.7% undervalued
intrinsic discount
-0.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Brighthouse Financial
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
US Aging Demographics Will Boost Annuity Demand
Key Takeaways Strong demand for retirement solutions and product innovation are driving revenue growth, sales volume, and market competitiveness for Brighthouse. Solid capital strength, disciplined expense management, and demographic tailwinds underpin profitability, financial flexibility, and long-term earnings stability.
View narrative
US$59.44
FV
21.3% undervalued
intrinsic discount
2.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
13 days ago
author updated this narrative
Rhythm Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Label Expansion And Global Healthcare Will Widen Future Market Opportunities
Key Takeaways Label expansion and global commercialization of IMCIVREE are set to drive substantial revenue growth and broaden market reach. Strong reimbursement infrastructure and promising pipeline developments enhance long-term earnings stability and product launch opportunities.
View narrative
US$104.57
FV
15.3% undervalued
intrinsic discount
67.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
13 days ago
author updated this narrative
Dun & Bradstreet Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Cloud Migration And AI Advancements Will Expand Compliance Reach
Key Takeaways Completion of technology modernization and an enhanced go-to-market approach are driving improved product mix, pricing, and deeper client relationships for long-term growth. Strong demand for compliance, risk analytics, and AI-powered solutions, along with recurring revenue expansion, supports sustainable revenue and margin stability.
View narrative
US$9.15
FV
0.4% undervalued
intrinsic discount
4.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
13 days ago
author updated this narrative
BrightSpring Health Services
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Home Health And Value-Based Care Will Redefine Service Delivery
Key Takeaways Growth is propelled by demographic trends, value-based care initiatives, and a strong pharmaceutical pipeline, boosting revenue and margin prospects. Investments in technology, efficiency, and targeted acquisitions support cost control, market expansion, and sustained earnings growth.
View narrative
US$28.10
FV
29.4% undervalued
intrinsic discount
8.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
13 days ago
author updated this narrative
Silicon Laboratories
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Smart Home Demand And IoT Trends Will Unlock Value
Key Takeaways Accelerated adoption of diverse IoT applications and next-generation products is driving higher customer demand and expanded growth opportunities across new and existing segments. Focus on ecosystem compatibility, energy efficiency, and supply chain resilience is enhancing customer loyalty, supporting margin improvement, and positioning the company for sustainable long-term gains.
View narrative
US$150.78
FV
15.9% undervalued
intrinsic discount
21.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
13 days ago
author updated this narrative
Baldwin Insurance Group
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
US Business Formation And Tech Investment Will Redefine Insurance
Key Takeaways Rapid growth in commercial insurance demand and robust client retention drive strong recurring revenue, margin expansion, and increased capital flexibility. Technology investments and specialty line expansion diversify revenue streams and position the company for sustained organic and advisory segment growth.
View narrative
US$47.63
FV
23.4% undervalued
intrinsic discount
13.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
13 days ago
author updated this narrative
Value any company in seconds
Popular companies